News
Hosted on MSN2mon
Immix Biopharma stock holds $7 target, Buy rating at H.C. WainwrightO n Tuesday, H.C. Wainwright maintained its optimistic stance on Immix Biopharma , Inc. (NASDAQ:IMMX), with analyst Robert Burns reiterating a Buy rating and a $7.00 price target on the company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback